PPP1R2P3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.26485497023532E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.32350028106509E-10 |
Normal-vs-Stage2 |
2.02870000000077E-05 |
Normal-vs-Stage3 |
5.66435787163755E-13 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
6.594200E-01 |
Stage1-vs-Stage3 |
7.999600E-04 |
Stage1-vs-Stage4 |
9.41439999957439E-07 |
Stage2-vs-Stage3 |
1.151790E-01 |
Stage2-vs-Stage4 |
1.200350E-02 |
Stage3-vs-Stage4 |
1.607630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.12818651590396E-12 |
Normal-vs-AfricanAmerican |
2.09920969496125E-12 |
Normal-vs-Asian |
1.954110E-02 |
Caucasian-vs-AfricanAmerican |
2.592000E-02 |
Caucasian-vs-Asian |
7.729400E-01 |
AfricanAmerican-vs-Asian |
2.046200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.1641356201817E-14 |
Normal-vs-Female |
7.47749639984363E-11 |
Male-vs-Female |
3.235600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.24729999999118E-05 |
Normal-vs-Age(41-60Yrs) |
2.39330000262328E-10 |
Normal-vs-Age(61-80Yrs) |
1.63247193540883E-12 |
Normal-vs-Age(81-100Yrs) |
7.87690000003671E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.349200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.917000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.879800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.841220E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.856800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.452400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.976300E-02 |
Normal-vs-Grade 2 |
1.42490000021311E-07 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62725388719309E-12 |
Grade 1-vs-Grade 2 |
4.070400E-01 |
Grade 1-vs-Grade 3 |
1.211580E-02 |
Grade 1-vs-Grade 4 |
2.178900E-03 |
Grade 2-vs-Grade 3 |
8.49860000000646E-05 |
Grade 2-vs-Grade 4 |
1.52180999999363E-05 |
Grade 3-vs-Grade 4 |
4.086500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.73870000028809E-07 |
Normal-vs-ccB subtype |
3.6409764092582E-12 |
ccA subtype-vs-ccB subtype |
3.247000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.63450372628427E-11 |
Normal-vs-N1 |
1.62115999999823E-05 |
N0-vs-N1 |
2.938400E-01 |
|
|